Two shots in one
Living With Diabetes, Research
Yesterday the US Food and Drug Administration approved two new medications – both are shots & each is a combination of two different classes of medication in one shot: a basal long-acting insulin and a GLP-1 receptor agonist. The Novo Nordisk product combines Tresiba, an insulin not yet available in Canada and Victoza while the Sanofi product […]